| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Semen Analysis | 46 | 2023 | 234 | 9.010 |
Why?
|
| Pesticide Residues | 16 | 2023 | 95 | 6.740 |
Why?
|
| Infertility | 32 | 2024 | 655 | 6.450 |
Why?
|
| Infertility, Female | 39 | 2024 | 759 | 5.650 |
Why?
|
| Hypertension, Pregnancy-Induced | 12 | 2024 | 518 | 5.150 |
Why?
|
| Fertility | 30 | 2023 | 773 | 4.940 |
Why?
|
| Diabetes, Gestational | 45 | 2024 | 1242 | 4.870 |
Why?
|
| Sperm Count | 25 | 2023 | 228 | 4.260 |
Why?
|
| Reproductive Techniques, Assisted | 29 | 2022 | 497 | 3.850 |
Why?
|
| Diet | 73 | 2024 | 8010 | 3.680 |
Why?
|
| Menstrual Cycle | 11 | 2024 | 536 | 3.490 |
Why?
|
| Abortion, Spontaneous | 12 | 2023 | 530 | 3.460 |
Why?
|
| Pregnancy | 174 | 2024 | 29749 | 3.220 |
Why?
|
| Nurses | 26 | 2024 | 2467 | 3.070 |
Why?
|
| Spermatozoa | 20 | 2020 | 631 | 3.050 |
Why?
|
| Vegetables | 19 | 2023 | 1196 | 2.960 |
Why?
|
| Semen | 16 | 2023 | 346 | 2.920 |
Why?
|
| Fruit | 19 | 2023 | 1160 | 2.910 |
Why?
|
| Infertility, Male | 17 | 2020 | 396 | 2.890 |
Why?
|
| Pre-Eclampsia | 11 | 2024 | 1229 | 2.860 |
Why?
|
| Dietary Fats | 19 | 2022 | 1992 | 2.840 |
Why?
|
| Body Mass Index | 68 | 2024 | 12914 | 2.770 |
Why?
|
| Prospective Studies | 188 | 2024 | 54303 | 2.570 |
Why?
|
| Preconception Care | 10 | 2021 | 139 | 2.460 |
Why?
|
| Trans Fatty Acids | 7 | 2022 | 155 | 2.400 |
Why?
|
| Pesticides | 11 | 2023 | 293 | 2.330 |
Why?
|
| Menstruation Disturbances | 5 | 2021 | 143 | 2.280 |
Why?
|
| Fertilization in Vitro | 24 | 2023 | 1292 | 2.280 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 11 | 2024 | 389 | 2.200 |
Why?
|
| Ovulation | 8 | 2016 | 181 | 2.080 |
Why?
|
| Dairy Products | 12 | 2019 | 494 | 2.060 |
Why?
|
| Pregnancy Outcome | 25 | 2024 | 2907 | 2.050 |
Why?
|
| Sperm Motility | 18 | 2023 | 265 | 2.040 |
Why?
|
| Overweight | 20 | 2024 | 2421 | 2.010 |
Why?
|
| Cesarean Section | 7 | 2021 | 1385 | 1.880 |
Why?
|
| Diet Surveys | 20 | 2021 | 1161 | 1.870 |
Why?
|
| Soy Foods | 4 | 2016 | 44 | 1.820 |
Why?
|
| Live Birth | 18 | 2021 | 512 | 1.810 |
Why?
|
| Feeding Behavior | 23 | 2024 | 3185 | 1.770 |
Why?
|
| Adult | 237 | 2024 | 219994 | 1.600 |
Why?
|
| Environmental Pollutants | 13 | 2024 | 1266 | 1.590 |
Why?
|
| Diabetes Mellitus, Type 2 | 28 | 2024 | 12293 | 1.570 |
Why?
|
| Female | 306 | 2024 | 391270 | 1.570 |
Why?
|
| Reproduction | 9 | 2023 | 646 | 1.560 |
Why?
|
| Seafood | 7 | 2018 | 390 | 1.510 |
Why?
|
| Caffeine | 7 | 2018 | 702 | 1.470 |
Why?
|
| Menarche | 9 | 2023 | 529 | 1.470 |
Why?
|
| Occupational Exposure | 11 | 2021 | 1809 | 1.410 |
Why?
|
| Pregnancy Rate | 20 | 2022 | 649 | 1.400 |
Why?
|
| Folic Acid | 12 | 2021 | 1309 | 1.400 |
Why?
|
| Meat | 6 | 2019 | 584 | 1.390 |
Why?
|
| Risk Factors | 120 | 2024 | 74359 | 1.390 |
Why?
|
| Dietary Supplements | 23 | 2024 | 3392 | 1.380 |
Why?
|
| Obesity | 34 | 2024 | 12922 | 1.380 |
Why?
|
| Humans | 391 | 2024 | 760621 | 1.370 |
Why?
|
| Agaricales | 2 | 2019 | 30 | 1.330 |
Why?
|
| Fatty Acids | 9 | 2023 | 1804 | 1.310 |
Why?
|
| Sweetening Agents | 6 | 2022 | 290 | 1.290 |
Why?
|
| Life Style | 20 | 2023 | 3896 | 1.280 |
Why?
|
| Adiposity | 9 | 2024 | 1858 | 1.280 |
Why?
|
| Cohort Studies | 69 | 2024 | 41335 | 1.250 |
Why?
|
| Premature Birth | 4 | 2023 | 1771 | 1.200 |
Why?
|
| Endometriosis | 13 | 2024 | 874 | 1.190 |
Why?
|
| Follicle Stimulating Hormone | 11 | 2023 | 725 | 1.170 |
Why?
|
| Fatty Acids, Omega-3 | 9 | 2022 | 1387 | 1.170 |
Why?
|
| Anovulation | 6 | 2016 | 54 | 1.130 |
Why?
|
| Phenols | 8 | 2023 | 514 | 1.120 |
Why?
|
| Anti-Mullerian Hormone | 9 | 2024 | 407 | 1.120 |
Why?
|
| Environmental Exposure | 18 | 2023 | 4412 | 1.100 |
Why?
|
| Delivery, Obstetric | 4 | 2021 | 932 | 1.100 |
Why?
|
| Weight Gain | 11 | 2024 | 2347 | 1.100 |
Why?
|
| Sexual Behavior | 10 | 2024 | 2086 | 1.090 |
Why?
|
| Eating | 7 | 2019 | 1539 | 1.060 |
Why?
|
| Coffee | 4 | 2022 | 582 | 1.050 |
Why?
|
| Fluorocarbons | 4 | 2024 | 488 | 1.030 |
Why?
|
| Phthalic Acids | 8 | 2023 | 476 | 1.030 |
Why?
|
| Vitamins | 10 | 2024 | 1634 | 0.980 |
Why?
|
| Menopause | 6 | 2024 | 1640 | 0.980 |
Why?
|
| Disinfectants | 3 | 2021 | 130 | 0.980 |
Why?
|
| Adolescent | 82 | 2024 | 87810 | 0.960 |
Why?
|
| Young Adult | 79 | 2024 | 58741 | 0.960 |
Why?
|
| Cannabis | 3 | 2023 | 436 | 0.960 |
Why?
|
| Carbonated Beverages | 5 | 2022 | 209 | 0.960 |
Why?
|
| Fertilization | 2 | 2023 | 197 | 0.950 |
Why?
|
| Diet, Mediterranean | 12 | 2024 | 735 | 0.910 |
Why?
|
| Waist Circumference | 5 | 2022 | 926 | 0.910 |
Why?
|
| Meat Products | 2 | 2014 | 96 | 0.910 |
Why?
|
| Prostatic Neoplasms | 14 | 2019 | 11345 | 0.910 |
Why?
|
| Pregnancy Complications | 10 | 2024 | 2942 | 0.880 |
Why?
|
| Ovarian Follicle | 9 | 2023 | 244 | 0.880 |
Why?
|
| Fatty Acids, Monounsaturated | 4 | 2022 | 190 | 0.870 |
Why?
|
| Cardiovascular Diseases | 14 | 2024 | 15757 | 0.860 |
Why?
|
| Endocrine Disruptors | 2 | 2023 | 263 | 0.850 |
Why?
|
| Male | 151 | 2024 | 359744 | 0.840 |
Why?
|
| Sperm Injections, Intracytoplasmic | 7 | 2021 | 156 | 0.830 |
Why?
|
| Gonadal Steroid Hormones | 5 | 2018 | 701 | 0.830 |
Why?
|
| Nutrition Assessment | 7 | 2015 | 727 | 0.830 |
Why?
|
| Food Contamination | 2 | 2023 | 192 | 0.810 |
Why?
|
| Birth Weight | 9 | 2024 | 2097 | 0.800 |
Why?
|
| Marijuana Smoking | 3 | 2019 | 257 | 0.780 |
Why?
|
| beta Carotene | 2 | 2019 | 524 | 0.760 |
Why?
|
| Menopause, Premature | 1 | 2022 | 125 | 0.750 |
Why?
|
| Stillbirth | 2 | 2014 | 368 | 0.750 |
Why?
|
| Denmark | 12 | 2021 | 760 | 0.750 |
Why?
|
| Longitudinal Studies | 27 | 2024 | 14495 | 0.730 |
Why?
|
| Testis | 3 | 2020 | 794 | 0.730 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2024 | 2496 | 0.710 |
Why?
|
| Incidence | 33 | 2024 | 21392 | 0.710 |
Why?
|
| Intention | 1 | 2023 | 345 | 0.700 |
Why?
|
| Maternal Mortality | 1 | 2023 | 300 | 0.690 |
Why?
|
| Nutritional Status | 6 | 2021 | 1607 | 0.680 |
Why?
|
| Fathers | 3 | 2021 | 376 | 0.680 |
Why?
|
| Child Abuse | 3 | 2023 | 1067 | 0.680 |
Why?
|
| Body Weight | 15 | 2024 | 4611 | 0.670 |
Why?
|
| Diethylhexyl Phthalate | 5 | 2023 | 83 | 0.670 |
Why?
|
| Infant, Low Birth Weight | 1 | 2024 | 859 | 0.670 |
Why?
|
| Beverages | 7 | 2022 | 820 | 0.660 |
Why?
|
| Exercise | 12 | 2021 | 5787 | 0.660 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2020 | 125 | 0.660 |
Why?
|
| Homosexuality, Female | 5 | 2021 | 159 | 0.650 |
Why?
|
| Sexual Maturation | 2 | 2019 | 260 | 0.650 |
Why?
|
| Paternal Exposure | 2 | 2019 | 94 | 0.640 |
Why?
|
| Fishes | 6 | 2018 | 601 | 0.640 |
Why?
|
| Benzhydryl Compounds | 5 | 2022 | 941 | 0.640 |
Why?
|
| Reproductive History | 2 | 2023 | 210 | 0.630 |
Why?
|
| Lifting | 2 | 2017 | 55 | 0.630 |
Why?
|
| Work Schedule Tolerance | 4 | 2024 | 551 | 0.610 |
Why?
|
| United States | 66 | 2024 | 72461 | 0.610 |
Why?
|
| Proportional Hazards Models | 21 | 2024 | 12531 | 0.610 |
Why?
|
| Heterosexuality | 7 | 2024 | 294 | 0.610 |
Why?
|
| Middle Aged | 90 | 2024 | 220352 | 0.610 |
Why?
|
| Neoplasms | 13 | 2023 | 22072 | 0.600 |
Why?
|
| Clothing | 1 | 2018 | 97 | 0.600 |
Why?
|
| Occupational Diseases | 4 | 2019 | 1486 | 0.600 |
Why?
|
| Parity | 8 | 2023 | 925 | 0.590 |
Why?
|
| Pyrethrins | 1 | 2017 | 44 | 0.590 |
Why?
|
| Mothers | 10 | 2023 | 2186 | 0.590 |
Why?
|
| Coitus | 1 | 2018 | 131 | 0.580 |
Why?
|
| Pregnancy, Ectopic | 1 | 2018 | 143 | 0.570 |
Why?
|
| Birth Intervals | 1 | 2017 | 51 | 0.570 |
Why?
|
| Longevity | 4 | 2024 | 1050 | 0.570 |
Why?
|
| Self Report | 15 | 2022 | 3711 | 0.560 |
Why?
|
| Dietary Proteins | 6 | 2018 | 949 | 0.560 |
Why?
|
| Erectile Dysfunction | 1 | 2020 | 452 | 0.560 |
Why?
|
| Child | 53 | 2024 | 79806 | 0.550 |
Why?
|
| Body Composition | 4 | 2022 | 2419 | 0.550 |
Why?
|
| Cross-Sectional Studies | 33 | 2024 | 25942 | 0.550 |
Why?
|
| Antioxidants | 5 | 2019 | 1667 | 0.550 |
Why?
|
| Fetal Development | 2 | 2021 | 766 | 0.550 |
Why?
|
| Phospholipids | 1 | 2020 | 789 | 0.550 |
Why?
|
| Follow-Up Studies | 38 | 2022 | 39261 | 0.540 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 655 | 0.530 |
Why?
|
| Linear Models | 15 | 2024 | 5877 | 0.530 |
Why?
|
| Sodium, Dietary | 1 | 2020 | 425 | 0.530 |
Why?
|
| Dietary Carbohydrates | 5 | 2022 | 892 | 0.530 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 516 | 0.530 |
Why?
|
| Vitamin E | 1 | 2020 | 872 | 0.520 |
Why?
|
| Weight Loss | 6 | 2023 | 2686 | 0.520 |
Why?
|
| Alcohol Drinking | 8 | 2021 | 4013 | 0.510 |
Why?
|
| Vitamin B Complex | 3 | 2019 | 297 | 0.510 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 1155 | 0.510 |
Why?
|
| Air Pollutants | 8 | 2023 | 2844 | 0.500 |
Why?
|
| Cause of Death | 3 | 2021 | 3725 | 0.500 |
Why?
|
| Diet Records | 4 | 2020 | 427 | 0.500 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 191 | 0.490 |
Why?
|
| Fetal Mortality | 1 | 2014 | 19 | 0.490 |
Why?
|
| Television | 4 | 2014 | 409 | 0.490 |
Why?
|
| Self-Assessment | 1 | 2017 | 393 | 0.480 |
Why?
|
| Infant, Newborn | 19 | 2023 | 26181 | 0.480 |
Why?
|
| Functional Food | 1 | 2014 | 20 | 0.470 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2014 | 389 | 0.470 |
Why?
|
| Air Pollution | 8 | 2023 | 2317 | 0.470 |
Why?
|
| Sexual Partners | 2 | 2019 | 753 | 0.470 |
Why?
|
| Work | 1 | 2015 | 194 | 0.460 |
Why?
|
| Diet, Vegetarian | 1 | 2016 | 180 | 0.460 |
Why?
|
| Mental Recall | 3 | 2017 | 1206 | 0.450 |
Why?
|
| Follicular Fluid | 3 | 2023 | 92 | 0.440 |
Why?
|
| Puberty | 3 | 2022 | 498 | 0.420 |
Why?
|
| Women's Health | 4 | 2017 | 2056 | 0.420 |
Why?
|
| Hypertension | 8 | 2024 | 8594 | 0.410 |
Why?
|
| Isoflavones | 2 | 2015 | 136 | 0.410 |
Why?
|
| Parabens | 3 | 2023 | 114 | 0.410 |
Why?
|
| Risk | 18 | 2021 | 9631 | 0.410 |
Why?
|
| Endometrial Neoplasms | 1 | 2022 | 1357 | 0.410 |
Why?
|
| Multivariate Analysis | 16 | 2019 | 12159 | 0.400 |
Why?
|
| Coronary Disease | 3 | 2024 | 5990 | 0.400 |
Why?
|
| Dietary Fiber | 3 | 2022 | 760 | 0.390 |
Why?
|
| Lipogenesis | 1 | 2013 | 210 | 0.390 |
Why?
|
| Adiponectin | 5 | 2024 | 1115 | 0.390 |
Why?
|
| Odds Ratio | 18 | 2022 | 9716 | 0.390 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2017 | 542 | 0.380 |
Why?
|
| Mercury | 3 | 2021 | 290 | 0.380 |
Why?
|
| Bisexuality | 4 | 2021 | 274 | 0.380 |
Why?
|
| Smoking | 9 | 2023 | 9073 | 0.380 |
Why?
|
| Insulin Resistance | 4 | 2021 | 3959 | 0.370 |
Why?
|
| Alkanesulfonic Acids | 3 | 2024 | 199 | 0.370 |
Why?
|
| Blood Glucose | 6 | 2021 | 6381 | 0.370 |
Why?
|
| Confidence Intervals | 6 | 2016 | 2932 | 0.370 |
Why?
|
| Citrus sinensis | 2 | 2020 | 14 | 0.360 |
Why?
|
| Anxiety | 7 | 2024 | 4538 | 0.350 |
Why?
|
| Data Collection | 3 | 2020 | 3315 | 0.350 |
Why?
|
| Hormones | 1 | 2014 | 867 | 0.350 |
Why?
|
| Birth Order | 2 | 2023 | 95 | 0.350 |
Why?
|
| Research Design | 6 | 2023 | 6180 | 0.340 |
Why?
|
| Testosterone | 5 | 2023 | 2470 | 0.340 |
Why?
|
| Blood Pressure | 3 | 2024 | 8525 | 0.340 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2024 | 377 | 0.340 |
Why?
|
| Vehicle Emissions | 3 | 2019 | 653 | 0.330 |
Why?
|
| Oocyte Retrieval | 5 | 2020 | 158 | 0.330 |
Why?
|
| Embryo Implantation | 4 | 2021 | 270 | 0.330 |
Why?
|
| Embryo Transfer | 4 | 2020 | 522 | 0.330 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2022 | 1375 | 0.320 |
Why?
|
| Seasons | 3 | 2021 | 1522 | 0.320 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 237 | 0.310 |
Why?
|
| Massachusetts | 11 | 2021 | 8803 | 0.310 |
Why?
|
| Depression, Postpartum | 2 | 2023 | 345 | 0.310 |
Why?
|
| Premenopause | 5 | 2024 | 1038 | 0.310 |
Why?
|
| Cattle | 1 | 2014 | 3847 | 0.310 |
Why?
|
| Autistic Disorder | 3 | 2022 | 1216 | 0.310 |
Why?
|
| New York | 3 | 2016 | 875 | 0.300 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2024 | 732 | 0.300 |
Why?
|
| Oleic Acid | 1 | 2008 | 92 | 0.290 |
Why?
|
| Birth Rate | 3 | 2019 | 168 | 0.290 |
Why?
|
| Depression | 10 | 2024 | 8044 | 0.290 |
Why?
|
| Michigan | 2 | 2018 | 342 | 0.290 |
Why?
|
| Demography | 4 | 2023 | 1650 | 0.280 |
Why?
|
| Texas | 2 | 2018 | 401 | 0.280 |
Why?
|
| Poultry | 2 | 2018 | 81 | 0.280 |
Why?
|
| Maternal Exposure | 3 | 2024 | 1045 | 0.280 |
Why?
|
| Linoleic Acid | 1 | 2008 | 159 | 0.280 |
Why?
|
| Cognition | 1 | 2024 | 6957 | 0.270 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1674 | 0.270 |
Why?
|
| Metabolome | 4 | 2023 | 982 | 0.270 |
Why?
|
| Logistic Models | 11 | 2018 | 13314 | 0.270 |
Why?
|
| Pandemics | 9 | 2024 | 8624 | 0.270 |
Why?
|
| Nutrition Surveys | 6 | 2021 | 1725 | 0.270 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 159 | 0.260 |
Why?
|
| Patient Compliance | 4 | 2019 | 2688 | 0.260 |
Why?
|
| Solanum tuberosum | 2 | 2016 | 40 | 0.260 |
Why?
|
| Vitamin D | 5 | 2019 | 3291 | 0.260 |
Why?
|
| Time Factors | 17 | 2021 | 40165 | 0.260 |
Why?
|
| Spain | 4 | 2019 | 488 | 0.250 |
Why?
|
| Risk Assessment | 15 | 2020 | 24123 | 0.240 |
Why?
|
| Milk | 3 | 2021 | 443 | 0.240 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2017 | 346 | 0.240 |
Why?
|
| Epidemiologic Studies | 3 | 2017 | 670 | 0.240 |
Why?
|
| Fish Oils | 2 | 2020 | 482 | 0.230 |
Why?
|
| Protective Clothing | 3 | 2020 | 103 | 0.230 |
Why?
|
| Pets | 1 | 2024 | 47 | 0.230 |
Why?
|
| Motor Activity | 4 | 2018 | 2687 | 0.230 |
Why?
|
| Reference Values | 4 | 2016 | 4925 | 0.230 |
Why?
|
| Luteinizing Hormone | 3 | 2021 | 820 | 0.230 |
Why?
|
| Lactation | 3 | 2022 | 397 | 0.220 |
Why?
|
| Aged | 32 | 2024 | 169152 | 0.220 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 20080 | 0.220 |
Why?
|
| Bariatric Surgery | 1 | 2013 | 1005 | 0.220 |
Why?
|
| Food Handling | 3 | 2024 | 155 | 0.210 |
Why?
|
| Ovulation Induction | 4 | 2023 | 277 | 0.210 |
Why?
|
| Postpartum Period | 3 | 2024 | 1167 | 0.210 |
Why?
|
| Oocytes | 4 | 2023 | 1165 | 0.210 |
Why?
|
| Hair | 2 | 2017 | 497 | 0.210 |
Why?
|
| Nursing Staff, Hospital | 2 | 2017 | 344 | 0.210 |
Why?
|
| Azoospermia | 2 | 2012 | 28 | 0.210 |
Why?
|
| Oligospermia | 2 | 2012 | 59 | 0.200 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 13630 | 0.200 |
Why?
|
| School Health Services | 1 | 2005 | 382 | 0.200 |
Why?
|
| Child, Preschool | 12 | 2024 | 42063 | 0.200 |
Why?
|
| Diet, Carbohydrate-Restricted | 2 | 2015 | 261 | 0.200 |
Why?
|
| Pregnancy Trimester, First | 3 | 2024 | 908 | 0.200 |
Why?
|
| Waist-Hip Ratio | 2 | 2020 | 516 | 0.200 |
Why?
|
| Food | 2 | 2017 | 771 | 0.200 |
Why?
|
| Case-Control Studies | 11 | 2022 | 22053 | 0.200 |
Why?
|
| Treatment Outcome | 21 | 2022 | 65017 | 0.200 |
Why?
|
| Azocines | 1 | 2021 | 21 | 0.200 |
Why?
|
| Pregnancy, Unplanned | 2 | 2019 | 88 | 0.190 |
Why?
|
| Reproductive Techniques | 1 | 2021 | 41 | 0.190 |
Why?
|
| Family Characteristics | 3 | 2016 | 1001 | 0.190 |
Why?
|
| Chromatography, Gas | 2 | 2012 | 151 | 0.190 |
Why?
|
| Food, Organic | 2 | 2018 | 35 | 0.190 |
Why?
|
| Boston | 9 | 2023 | 9280 | 0.190 |
Why?
|
| Academic Medical Centers | 5 | 2017 | 2754 | 0.180 |
Why?
|
| Prenatal Care | 2 | 2018 | 1129 | 0.180 |
Why?
|
| Calcium, Dietary | 2 | 2013 | 531 | 0.180 |
Why?
|
| Gonadal Hormones | 1 | 2020 | 30 | 0.180 |
Why?
|
| Nitrogen Dioxide | 2 | 2020 | 512 | 0.170 |
Why?
|
| Singapore | 1 | 2021 | 288 | 0.170 |
Why?
|
| Ownership | 1 | 2022 | 339 | 0.170 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2021 | 268 | 0.170 |
Why?
|
| Amenorrhea | 1 | 2023 | 480 | 0.170 |
Why?
|
| Metals | 1 | 2024 | 736 | 0.170 |
Why?
|
| Magnesium | 2 | 2013 | 810 | 0.170 |
Why?
|
| Trihalomethanes | 1 | 2019 | 49 | 0.170 |
Why?
|
| Genomic Imprinting | 1 | 2021 | 330 | 0.170 |
Why?
|
| Obesity, Abdominal | 2 | 2021 | 374 | 0.170 |
Why?
|
| North America | 1 | 2023 | 1284 | 0.170 |
Why?
|
| Hand Strength | 1 | 2022 | 452 | 0.170 |
Why?
|
| Sex Hormone-Binding Globulin | 4 | 2020 | 546 | 0.160 |
Why?
|
| Erythrocyte Membrane | 1 | 2020 | 439 | 0.160 |
Why?
|
| Benzophenones | 1 | 2019 | 58 | 0.160 |
Why?
|
| Health Surveys | 3 | 2021 | 4063 | 0.160 |
Why?
|
| Vaccination | 2 | 2022 | 3361 | 0.160 |
Why?
|
| Sex Offenses | 1 | 2023 | 351 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10344 | 0.160 |
Why?
|
| Estradiol | 6 | 2023 | 1932 | 0.160 |
Why?
|
| Animals | 21 | 2024 | 167963 | 0.160 |
Why?
|
| Shellfish | 2 | 2018 | 37 | 0.160 |
Why?
|
| Sterilization, Tubal | 1 | 2018 | 80 | 0.160 |
Why?
|
| Breast Feeding | 6 | 2024 | 1355 | 0.160 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 139 | 0.150 |
Why?
|
| Carbohydrates | 1 | 2020 | 388 | 0.150 |
Why?
|
| Education, Continuing | 1 | 2019 | 114 | 0.150 |
Why?
|
| Iron | 1 | 2006 | 1786 | 0.150 |
Why?
|
| Progesterone | 3 | 2020 | 742 | 0.150 |
Why?
|
| Nursing | 1 | 2017 | 34 | 0.150 |
Why?
|
| Leiomyoma | 1 | 2022 | 654 | 0.150 |
Why?
|
| Parents | 2 | 2023 | 3549 | 0.150 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15840 | 0.150 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2018 | 2659 | 0.140 |
Why?
|
| Spermatogenesis | 2 | 2019 | 257 | 0.140 |
Why?
|
| Automobiles | 1 | 2018 | 111 | 0.140 |
Why?
|
| Intrauterine Devices | 1 | 2018 | 114 | 0.140 |
Why?
|
| Vitamin D Deficiency | 2 | 2017 | 1379 | 0.140 |
Why?
|
| Cell Shape | 2 | 2015 | 372 | 0.140 |
Why?
|
| Nutrition Policy | 1 | 2021 | 470 | 0.140 |
Why?
|
| Health Behavior | 5 | 2024 | 2622 | 0.140 |
Why?
|
| Contraception Behavior | 1 | 2019 | 180 | 0.140 |
Why?
|
| Sarcopenia | 1 | 2022 | 372 | 0.140 |
Why?
|
| Hyperlipidemias | 1 | 2022 | 782 | 0.140 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2016 | 296 | 0.140 |
Why?
|
| Insemination, Artificial | 2 | 2014 | 99 | 0.140 |
Why?
|
| Ozone | 1 | 2020 | 477 | 0.140 |
Why?
|
| Sperm-Ovum Interactions | 1 | 2016 | 23 | 0.140 |
Why?
|
| Habits | 1 | 2017 | 146 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 27 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2018 | 363 | 0.140 |
Why?
|
| Family Planning Services | 1 | 2019 | 265 | 0.140 |
Why?
|
| Men's Health | 1 | 2017 | 70 | 0.140 |
Why?
|
| Anthropometry | 1 | 2021 | 1348 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2017 | 3215 | 0.140 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 117 | 0.140 |
Why?
|
| Ovary | 1 | 2021 | 958 | 0.140 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2016 | 40 | 0.140 |
Why?
|
| Sulfones | 1 | 2019 | 447 | 0.140 |
Why?
|
| Inflammation | 5 | 2021 | 10756 | 0.140 |
Why?
|
| Energy Intake | 5 | 2024 | 2129 | 0.140 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2019 | 255 | 0.140 |
Why?
|
| American Heart Association | 1 | 2021 | 1081 | 0.140 |
Why?
|
| Particulate Matter | 4 | 2023 | 2559 | 0.140 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2022 | 1153 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2024 | 895 | 0.130 |
Why?
|
| Survival Rate | 3 | 2015 | 12808 | 0.130 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 463 | 0.130 |
Why?
|
| Glycemic Index | 3 | 2022 | 396 | 0.130 |
Why?
|
| Phytoestrogens | 1 | 2016 | 59 | 0.130 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 883 | 0.130 |
Why?
|
| Leptin | 2 | 2024 | 1591 | 0.130 |
Why?
|
| DNA Methylation | 2 | 2021 | 4373 | 0.130 |
Why?
|
| Stress, Psychological | 4 | 2022 | 4446 | 0.130 |
Why?
|
| Water Pollutants, Chemical | 1 | 2019 | 354 | 0.130 |
Why?
|
| Contraception | 1 | 2019 | 349 | 0.130 |
Why?
|
| Dietary Sucrose | 1 | 2017 | 244 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 227 | 0.130 |
Why?
|
| Calcifediol | 1 | 2016 | 161 | 0.130 |
Why?
|
| Circadian Rhythm | 2 | 2024 | 2571 | 0.130 |
Why?
|
| Phlebotomy | 1 | 2016 | 137 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 1 | 2018 | 1705 | 0.130 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2015 | 52 | 0.130 |
Why?
|
| Ubiquinone | 1 | 2016 | 183 | 0.120 |
Why?
|
| Beer | 1 | 2015 | 134 | 0.120 |
Why?
|
| Iron, Dietary | 1 | 2016 | 148 | 0.120 |
Why?
|
| C-Reactive Protein | 2 | 2017 | 3839 | 0.120 |
Why?
|
| Wine | 1 | 2015 | 167 | 0.120 |
Why?
|
| Tea | 1 | 2016 | 284 | 0.120 |
Why?
|
| Androstanes | 1 | 2014 | 20 | 0.120 |
Why?
|
| Women, Working | 1 | 2015 | 86 | 0.120 |
Why?
|
| Temperature | 1 | 2021 | 2221 | 0.120 |
Why?
|
| Diet, Fat-Restricted | 2 | 2014 | 330 | 0.120 |
Why?
|
| Blastocyst | 1 | 2017 | 433 | 0.120 |
Why?
|
| Regression Analysis | 5 | 2017 | 6360 | 0.120 |
Why?
|
| Triglycerides | 1 | 2022 | 2476 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3465 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 995 | 0.110 |
Why?
|
| Growth | 1 | 2016 | 365 | 0.110 |
Why?
|
| Abortion, Induced | 1 | 2019 | 460 | 0.110 |
Why?
|
| Fertility Agents, Female | 1 | 2014 | 101 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2019 | 869 | 0.110 |
Why?
|
| Iron Overload | 1 | 2016 | 240 | 0.110 |
Why?
|
| Adolescent Development | 1 | 2017 | 282 | 0.110 |
Why?
|
| Government Programs | 1 | 2016 | 280 | 0.110 |
Why?
|
| Occupational Health | 2 | 2017 | 805 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10827 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 704 | 0.110 |
Why?
|
| Cholesterol, Dietary | 1 | 2014 | 223 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2020 | 1168 | 0.110 |
Why?
|
| Cheese | 1 | 2013 | 38 | 0.110 |
Why?
|
| Bayes Theorem | 4 | 2023 | 2326 | 0.110 |
Why?
|
| Housing | 1 | 2018 | 665 | 0.110 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 58995 | 0.110 |
Why?
|
| Insulin | 4 | 2021 | 6597 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2019 | 778 | 0.110 |
Why?
|
| Sleep | 3 | 2024 | 4751 | 0.110 |
Why?
|
| Cholesterol | 1 | 2022 | 2924 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 686 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3085 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 522 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2022 | 80372 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2016 | 601 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3205 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2020 | 3106 | 0.100 |
Why?
|
| Research | 2 | 2023 | 1974 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 2 | 2018 | 1174 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2018 | 1435 | 0.100 |
Why?
|
| Fast Foods | 2 | 2024 | 210 | 0.090 |
Why?
|
| Gestational Age | 2 | 2019 | 3565 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2015 | 487 | 0.090 |
Why?
|
| Leisure Activities | 1 | 2013 | 306 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 7021 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2016 | 1376 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 15789 | 0.090 |
Why?
|
| Age Factors | 6 | 2024 | 18416 | 0.090 |
Why?
|
| Heart | 1 | 2024 | 4393 | 0.090 |
Why?
|
| Diet, Reducing | 1 | 2014 | 488 | 0.090 |
Why?
|
| Androgens | 1 | 2018 | 1291 | 0.090 |
Why?
|
| Health Status | 1 | 2023 | 4081 | 0.090 |
Why?
|
| Colombia | 3 | 2009 | 276 | 0.090 |
Why?
|
| Gloves, Protective | 2 | 2020 | 23 | 0.090 |
Why?
|
| Health Personnel | 2 | 2021 | 3310 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 580 | 0.090 |
Why?
|
| Loneliness | 2 | 2022 | 197 | 0.090 |
Why?
|
| Mortality | 1 | 2021 | 2916 | 0.090 |
Why?
|
| Prevalence | 4 | 2020 | 15687 | 0.080 |
Why?
|
| Skinfold Thickness | 2 | 2009 | 158 | 0.080 |
Why?
|
| Asthma | 2 | 2021 | 6172 | 0.080 |
Why?
|
| Physical Examination | 1 | 2016 | 1244 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2010 | 660 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2014 | 665 | 0.080 |
Why?
|
| Dementia | 1 | 2024 | 2649 | 0.080 |
Why?
|
| Age Distribution | 3 | 2017 | 2893 | 0.080 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 22 | 0.080 |
Why?
|
| Guideline Adherence | 2 | 2016 | 2283 | 0.080 |
Why?
|
| Disease Progression | 5 | 2019 | 13502 | 0.080 |
Why?
|
| Ethanol | 1 | 2015 | 1323 | 0.080 |
Why?
|
| Metabolomics | 1 | 2018 | 1628 | 0.080 |
Why?
|
| Contraceptive Agents | 2 | 2020 | 145 | 0.080 |
Why?
|
| Recurrence | 1 | 2021 | 8482 | 0.080 |
Why?
|
| Ohio | 1 | 2009 | 333 | 0.080 |
Why?
|
| Republic of Korea | 2 | 2023 | 566 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 2101 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2021 | 2809 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 1607 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2013 | 707 | 0.080 |
Why?
|
| Sex Factors | 4 | 2019 | 10547 | 0.080 |
Why?
|
| Nutritive Value | 2 | 2021 | 349 | 0.080 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2024 | 582 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 2 | 2017 | 926 | 0.070 |
Why?
|
| Inhibins | 2 | 2020 | 209 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 2003 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 3986 | 0.070 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 7806 | 0.070 |
Why?
|
| Medical Records | 2 | 2017 | 1407 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 934 | 0.070 |
Why?
|
| Glioma | 1 | 2022 | 3420 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 17790 | 0.070 |
Why?
|
| Telemedicine | 2 | 2024 | 3018 | 0.070 |
Why?
|
| Lipids | 3 | 2024 | 3336 | 0.070 |
Why?
|
| Video Games | 1 | 2009 | 190 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4899 | 0.070 |
Why?
|
| Postmenopause | 1 | 2015 | 2509 | 0.070 |
Why?
|
| Bacteria | 1 | 2017 | 2199 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15289 | 0.070 |
Why?
|
| Homicide | 1 | 2009 | 295 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3517 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2019 | 3426 | 0.070 |
Why?
|
| Health Promotion | 1 | 2018 | 2206 | 0.070 |
Why?
|
| Software | 1 | 2020 | 4419 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2016 | 2869 | 0.060 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2007 | 225 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6238 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2013 | 4035 | 0.060 |
Why?
|
| Maternal Age | 2 | 2020 | 807 | 0.060 |
Why?
|
| Food Supply | 1 | 2011 | 542 | 0.060 |
Why?
|
| Body Height | 2 | 2016 | 1570 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3758 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 10182 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 3242 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2022 | 613 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2024 | 6796 | 0.060 |
Why?
|
| Thyrotropin | 2 | 2020 | 832 | 0.060 |
Why?
|
| Prognosis | 5 | 2019 | 29658 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 12626 | 0.060 |
Why?
|
| Social Environment | 1 | 2009 | 1022 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2007 | 484 | 0.060 |
Why?
|
| Agriculture | 1 | 2005 | 190 | 0.060 |
Why?
|
| Gonadotropins | 2 | 2015 | 241 | 0.060 |
Why?
|
| Comorbidity | 4 | 2022 | 10551 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 8552 | 0.060 |
Why?
|
| China | 2 | 2019 | 2339 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8515 | 0.050 |
Why?
|
| Soil | 1 | 2023 | 109 | 0.050 |
Why?
|
| Infant | 6 | 2020 | 36060 | 0.050 |
Why?
|
| Taiwan | 1 | 2024 | 505 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2020 | 8555 | 0.050 |
Why?
|
| Placebos | 1 | 2007 | 1668 | 0.050 |
Why?
|
| Violence | 1 | 2009 | 927 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2024 | 406 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 513 | 0.050 |
Why?
|
| Environmental Monitoring | 2 | 2019 | 1441 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 11891 | 0.050 |
Why?
|
| Stroke | 1 | 2024 | 9962 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2024 | 316 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 2696 | 0.050 |
Why?
|
| Object Attachment | 1 | 2024 | 324 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2007 | 2025 | 0.050 |
Why?
|
| France | 2 | 2012 | 511 | 0.050 |
Why?
|
| C-Peptide | 1 | 2022 | 433 | 0.050 |
Why?
|
| Missouri | 1 | 2020 | 114 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11152 | 0.040 |
Why?
|
| Plants | 1 | 2021 | 317 | 0.040 |
Why?
|
| Glutens | 1 | 2022 | 240 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 13981 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5201 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 404 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 81 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7475 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3841 | 0.040 |
Why?
|
| Prostate | 1 | 2007 | 1793 | 0.040 |
Why?
|
| Reproductive Health Services | 1 | 2019 | 87 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 294 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 4878 | 0.040 |
Why?
|
| Dental Health Surveys | 1 | 2018 | 39 | 0.040 |
Why?
|
| Women | 1 | 2020 | 225 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2023 | 869 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14660 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 1381 | 0.040 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 162 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 252 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2019 | 416 | 0.040 |
Why?
|
| Workplace | 1 | 2024 | 857 | 0.040 |
Why?
|
| Plasma | 1 | 2021 | 584 | 0.040 |
Why?
|
| Cell Count | 1 | 2021 | 1835 | 0.040 |
Why?
|
| Climate | 1 | 2018 | 147 | 0.040 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 403 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1050 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2020 | 495 | 0.040 |
Why?
|
| Eggs | 1 | 2018 | 183 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3301 | 0.030 |
Why?
|
| Respiratory Protective Devices | 1 | 2017 | 47 | 0.030 |
Why?
|
| Age of Onset | 2 | 2017 | 3301 | 0.030 |
Why?
|
| Walking | 1 | 2024 | 1189 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 606 | 0.030 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2016 | 62 | 0.030 |
Why?
|
| Endometrium | 1 | 2019 | 403 | 0.030 |
Why?
|
| Immunoassay | 1 | 2019 | 746 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2021 | 5961 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 661 | 0.030 |
Why?
|
| Public Health | 2 | 2020 | 2653 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2017 | 507 | 0.030 |
Why?
|
| Adult Children | 1 | 2016 | 103 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 783 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 21025 | 0.030 |
Why?
|
| Pectinidae | 1 | 2015 | 5 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 987 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2128 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 912 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2019 | 699 | 0.030 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2016 | 120 | 0.030 |
Why?
|
| Organophosphorus Compounds | 1 | 2016 | 202 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2016 | 131 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2021 | 1343 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2014 | 56 | 0.030 |
Why?
|
| Physicians | 1 | 2012 | 4591 | 0.030 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 491 | 0.030 |
Why?
|
| Clomiphene | 1 | 2014 | 71 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 1221 | 0.030 |
Why?
|
| Heme | 1 | 2016 | 313 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 998 | 0.030 |
Why?
|
| Internal-External Control | 1 | 2015 | 359 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2061 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1895 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2016 | 965 | 0.030 |
Why?
|
| Family Health | 1 | 2018 | 1257 | 0.030 |
Why?
|
| Phenotype | 2 | 2024 | 16546 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2022 | 3682 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12427 | 0.030 |
Why?
|
| Drug Utilization Review | 1 | 2014 | 251 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1189 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 597 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2024 | 1830 | 0.030 |
Why?
|
| Child Behavior | 1 | 2018 | 847 | 0.030 |
Why?
|
| Minority Groups | 1 | 2019 | 1201 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 2295 | 0.030 |
Why?
|
| Curriculum | 1 | 2005 | 3718 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2020 | 1370 | 0.020 |
Why?
|
| Organ Size | 1 | 2017 | 2254 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 1343 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2014 | 309 | 0.020 |
Why?
|
| Particle Size | 1 | 2016 | 1644 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 1809 | 0.020 |
Why?
|
| Workload | 1 | 2017 | 847 | 0.020 |
Why?
|
| Employment | 1 | 2017 | 1112 | 0.020 |
Why?
|
| Universities | 1 | 2015 | 992 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1484 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2024 | 9287 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 368 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 791 | 0.020 |
Why?
|
| Sexual Development | 1 | 2009 | 40 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 1190 | 0.020 |
Why?
|
| Economics | 1 | 2009 | 141 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 6853 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2018 | 2062 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3562 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6898 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 9530 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2435 | 0.020 |
Why?
|
| Mexico | 1 | 2009 | 760 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1500 | 0.020 |
Why?
|
| Income | 1 | 2014 | 1875 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3928 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6551 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5397 | 0.010 |
Why?
|
| Aging | 1 | 2023 | 8651 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9467 | 0.010 |
Why?
|
| Video Recording | 1 | 2009 | 955 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10446 | 0.010 |
Why?
|
| Genotype | 1 | 2018 | 12960 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16939 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2014 | 1939 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10790 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4283 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8056 | 0.010 |
Why?
|